Immune monitoring for advanced cell therapy trials in transplantation: which assays and when?

Immune monitoring for advanced cell therapy trials in transplantation: which assays and when?

A number of immune regulatory cellular therapies, including regulatory T cells and mesenchymal stromal cells, have emerged as novel alternative therapies for the control of transplant alloresponses. Clinical studies have demonstrated their feasibility and safety, however developing our understanding...

Полное описание

Библиографические подробности
Главные авторы:	Stark, HL, Wang, HC, Kuburic, J, Alzhrani, A, Hester, J, Issa, F
Формат:	Journal article
Язык:	English
Опубликовано:	Frontiers Media 2021

Схожие документы

Immune Monitoring for Advanced Cell Therapy Trials in Transplantation: Which Assays and When?
по: Helen L. Stark, и др.
Опубликовано: (2021-03-01)

An exploration of regulatory T cells in transplantation: cell therapy development and immune monitoring
по: Alzhrani, AI
Опубликовано: (2021)

Biomarkers and surrogates of acute rejection in vascularized composite allograft transplantation
по: Honeyman, C, и др.
Опубликовано: (2021)

Biomarker and surrogate development in vascularised composite allograft transplantation: current progress and future challenges
по: Honeyman, C, и др.
Опубликовано: (2020)

Immune Monitoring Assay for Extracorporeal Photopheresis Treatment Optimization After Heart Transplantation
по: Maja-Theresa Dieterlen, и др.
Опубликовано: (2021-08-01)

Feasibility, long‐term safety and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients
по: Harden, PN, и др.
Опубликовано: (2020)

Regulatory immune cells in transplantation.
по: Wood, K, и др.
Опубликовано: (2012)

When to refer adult patients with congenital heart disease for transplantation: Which criteria to use, which work-up?
по: Alexander Van De Bruaene, и др.
Опубликовано: (2021-08-01)

The where and when of T cell regulation in transplantation.
по: Issa, F, и др.
Опубликовано: (2013)

The where and when of T cell regulation in transplantation
по: Issa, F, и др.
Опубликовано: (2013)

Identification, selection, and expansion of non-gene modified alloantigen-reactive Tregs for clinical therapeutic use
по: Alzhrani, A, и др.
Опубликовано: (2020)

Regulatory B cells in transplantation: roadmaps to clinic
по: Beckett, J, и др.
Опубликовано: (2020)

Comprehensive Immune Monitoring of Clinical Trials to Advance Human Immunotherapy
по: Felix J. Hartmann, и др.
Опубликовано: (2019-07-01)

DIGITAL PMMA, WHEN AND WHICH
по: Andreea Mariana Bănățeanu, и др.
Опубликовано: (2024-12-01)

Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients.
по: Hyeyoung Lee, и др.
Опубликовано: (2017-01-01)

Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients
по: Dominika Deborska-Materkowska, и др.
Опубликовано: (2018-04-01)

Deciphering the contribution of γδ T cells to outcomes in transplantation
по: McCallion, O, и др.
Опубликовано: (2018)

The Exacerbation of Chronic Obstructive Pulmonary Disease: Which Symptom is Most Important to Monitor?
по: Jacobson PK, и др.
Опубликовано: (2023-07-01)

A CRISPR-based assay for the detection of opportunistic infections post-transplantation and for the monitoring of transplant rejection
по: Kaminski, Michael M., и др.
Опубликовано: (2020)

Evaluation of Minitubers Yield and Scaling which Produced from Microtubers Transplanting Using Soilless Culture Technique
по: Falah Hassan Issa
Опубликовано: (2017-06-01)

Cerebrovascular neuroimaging: Which tests and when?
по: Michael Hoffmann
Опубликовано: (1996-09-01)

Chimeric antigen receptors and regulatory T cells: the potential for HLA-specific immunosuppression in transplantation
по: Wright, S, и др.
Опубликовано: (2021)

Opportunities for high-plex spatial transcriptomics in solid organ transplantation
по: Cross, AR, и др.
Опубликовано: (2023)

Which choice of therapy when many are available? Current systemic therapies for advanced hepatocellular carcinoma
по: Nicola Personeni, и др.
Опубликовано: (2020-03-01)

Towards regulatory cellular therapies in solid organ transplantation
по: Bottomley, MJ, и др.
Опубликовано: (2021)

Late treatment with autologous expanded regulatory T-cell therapy after alemtuzumab induction is safe and facilitates immunosuppression minimization in living donor renal transplantation
по: Brook, MO, и др.
Опубликовано: (2024)

Infections in transplant “Bugs which bug transplantation in India”
по: Manisha Sahay
Опубликовано: (2017-01-01)

What moves where when in which languages?
по: Richards, Norvin W. (Norvin Waldemar), 1971-
Опубликовано: (2008)

Investigations in West Syndrome: Which, When and Why
по: Richard E Appleton
Опубликовано: (2015-06-01)

Characterising the immune response to combined skin and solid organ transplants
по: Stark, H
Опубликовано: (2022)

Editorial: Personalized nutrition with polyphenols—which, for whom, when and how?
по: Antje R. Weseler, и др.
Опубликовано: (2023-05-01)

IL‐33 drives the production of mouse regulatory T cells with enhanced in vivo suppressive activity in skin transplantation
по: Kawai, K, и др.
Опубликовано: (2020)

Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype.
по: Carroll, R, и др.
Опубликовано: (2013)

Imaging the cellular components of the immune system for advancing diagnosis and immunotherapy of cancers
по: K. Bhise, и др.
Опубликовано: (2021-06-01)

Extracorporial Knots in Laparoscopic Surgery: Which, When, and How
по: Omar Salem Khattab
Опубликовано: (2008-10-01)

Alternatives to norepinephrine in septic shock: Which agents and when?
по: Mathieu Jozwiak
Опубликовано: (2022-10-01)

Which Test to Perform for Cystic hydatic Diagnosis and When?
по: Zahra Arab-Mazar, и др.
Опубликовано: (2020-06-01)

When will European Muslim population be majority and in which country?
по: Pierre Rostan, и др.
Опубликовано: (2020-09-01)

Stent for Crohn’s disease strictures: Which one and when?
по: Alain Attar
Опубликовано: (2016-03-01)

Blood component therapy: Which, when and how much
по: Rajesh Chand Arya, и др.
Опубликовано: (2011-01-01)